tradingkey.logo

STRATA Skin Sciences Inc

SSKN
1.270USD
+0.050+4.10%
收盤 12/24, 13:00美東報價延遲15分鐘
6.69M總市值
虧損本益比TTM

STRATA Skin Sciences Inc

1.270
+0.050+4.10%

關於 STRATA Skin Sciences Inc 公司

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

STRATA Skin Sciences Inc簡介

公司代碼SSKN
公司名稱STRATA Skin Sciences Inc
上市日期Oct 28, 2005
CEORafaeli (Dolev)
員工數量106
證券類型Ordinary Share
年結日Oct 28
公司地址5 Walnut Grove Drive, Suite 140
城市HORSHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編19044
電話12156193200
網址https://www.strataskinsciences.com/
公司代碼SSKN
上市日期Oct 28, 2005
CEORafaeli (Dolev)

STRATA Skin Sciences Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States (Country)
5.06M
66.03%
China
1.66M
21.65%
Foreign
456.00K
5.95%
Middle East
307.00K
4.01%
Other foreign
181.00K
2.36%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月15日 週六
更新時間: 11月15日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
其他
51.60%
持股股東
持股股東
佔比
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
其他
51.60%
股東類型
持股股東
佔比
Private Equity
24.49%
Investment Advisor/Hedge Fund
9.60%
Hedge Fund
8.62%
Corporation
6.21%
Investment Advisor
1.36%
Individual Investor
0.18%
其他
49.54%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
40
2.60M
49.33%
-171.52K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
2023Q2
52
2.46M
70.54%
-108.10K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Accelmed Growth Partners Management Ltd
1.44M
27.37%
--
--
Sep 04, 2025
22NW, LP
537.00K
10.19%
--
--
Jun 30, 2025
Nantahala Capital Management, LLC
403.92K
7.67%
--
--
Jun 30, 2025
Lincoln Alternative Strategies LLC
365.85K
6.94%
+365.85K
--
Sep 03, 2025
Renaissance Technologies LLC
98.03K
1.86%
-3.80K
-3.73%
Jun 30, 2025
The Vanguard Group, Inc.
84.63K
1.61%
--
--
Jun 30, 2025
Azzad Asset Management, Inc.
12.00K
0.23%
+1.00K
+9.09%
Jun 30, 2025
Geode Capital Management, L.L.C.
18.19K
0.35%
-76.00
-0.42%
Jun 30, 2025
MGO One Seven LLC
17.14K
0.33%
--
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
公告日期
類型
比率
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1

常見問題

STRATA Skin Sciences Inc的前五大股東是誰?

STRATA Skin Sciences Inc的前五大股東如下:
Accelmed Growth Partners Management Ltd
持有股份:1.44M
佔總股份比例:27.37%。
22NW, LP
持有股份:537.00K
佔總股份比例:10.19%。
Nantahala Capital Management, LLC
持有股份:403.92K
佔總股份比例:7.67%。
Lincoln Alternative Strategies LLC
持有股份:365.85K
佔總股份比例:6.94%。
Renaissance Technologies LLC
持有股份:98.03K
佔總股份比例:1.86%。

STRATA Skin Sciences Inc的前三大股東類型是什麼?

STRATA Skin Sciences Inc 的前三大股東類型分別是:
Accelmed Growth Partners Management Ltd
22NW, LP
Nantahala Capital Management, LLC

有多少機構持有STRATA Skin Sciences Inc(SSKN)的股份?

截至2025Q3,共有40家機構持有STRATA Skin Sciences Inc的股份,合計持有的股份價值約為2.60M,占公司總股份的49.33% 。與2025Q2相比,機構持股有所增加,增幅為-18.69%。

哪個業務部門對STRATA Skin Sciences Inc的收入貢獻最大?

在FY2025Q2,--業務部門對STRATA Skin Sciences Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI